V. Carriere, L. Roussel, and N. Ortega, IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo, Proceedings of the National Academy of Sciences, vol.21, issue.19, pp.282-287, 2007.
DOI : 10.1128/MCB.21.19.6484-6494.2001

N. T. Martin and M. U. Martin, Interleukin 33 is a guardian of barriers and a local alarmin, Nature Immunology, vol.2014, issue.2, pp.122-131, 2016.
DOI : 10.1371/journal.pone.0011944

O. Rostan, M. I. Arshad, C. Piquet-pellorce, F. Robert-gangneux, J. P. Gangneux et al., Crucial and Diverse Role of the Interleukin-33/ST2 Axis in Infectious Diseases, Infection and Immunity, vol.83, issue.5, pp.1738-1748, 2015.
DOI : 10.1128/IAI.02908-14

J. Schmitz, A. Owyang, and E. Oldham, IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines, Immunity, vol.23, issue.5, pp.479-490, 2005.
DOI : 10.1016/j.immuni.2005.09.015

M. I. Arshad, M. Rauch, and A. L. Helgoualc-'h, NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis, European Journal of Immunology, vol.41, issue.8, pp.2341-2348, 2011.
DOI : 10.1002/eji.201041006

URL : https://hal.archives-ouvertes.fr/hal-00681990

C. Cayrol and J. Girard, The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1, Proceedings of the National Academy of Sciences, vol.6, issue.2, pp.9021-9026, 2009.
DOI : 10.1038/ni1158

URL : http://www.pnas.org/content/106/22/9021.full.pdf

E. Lefrançais, S. Roga, and V. Gautier, IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G, Proceedings of the National Academy of Sciences, vol.387, issue.1, pp.1673-1678, 2012.
DOI : 10.1016/j.bbrc.2009.07.018

A. S. Mirchandani, R. J. Salmond, and F. Y. Liew, Interleukin-33 and the function of innate lymphoid cells, Trends in Immunology, vol.33, issue.8, pp.389-396, 2012.
DOI : 10.1016/j.it.2012.04.005

C. Baumann, W. V. Bonilla, and A. Fröhlich, T-bet??? and STAT4???dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses, Proceedings of the National Academy of Sciences, vol.391, issue.6665, pp.4056-4061, 2015.
DOI : 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O

URL : http://www.pnas.org/content/112/13/4056.full.pdf

W. V. Bonilla, A. Fröhlich, and K. Senn, The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses, Science, vol.74, issue.15, pp.984-989, 2012.
DOI : 10.1128/JVI.74.15.6964-6974.2000

M. I. Arshad, H. A. Khan, G. Noel, C. Piquet-pellorce, and M. Samson, Potential Therapeutic Aspects of Alarmin Cytokine Interleukin 33 or Its Inhibitors in Various Diseases, Clinical Therapeutics, vol.38, issue.5, pp.1000-1016, 2016.
DOI : 10.1016/j.clinthera.2016.02.021

URL : https://hal.archives-ouvertes.fr/hal-01295637

F. Y. Liew, J. P. Girard, and H. R. Turnquist, Interleukin-33 in health and disease, Nature Reviews Immunology, vol.2013, issue.11, pp.676-689, 2016.
DOI : 10.1186/ar4143

P. Marvie, M. Lisbonne, and A. L. Helgoualc-'h, Interleukin-33 overexpression is associated with liver fibrosis in mice and humans, Journal of Cellular and Molecular Medicine, vol.190, issue.6b, pp.1726-1739, 2010.
DOI : 10.4049/jimmunol.173.6.4020

URL : https://hal.archives-ouvertes.fr/hal-00660257

G. A. Roth, M. Zimmermann, and B. A. Lubsczyk, Up-Regulation of Interleukin 33 and Soluble ST2 Serum Levels in Liver Failure, Journal of Surgical Research, vol.163, issue.2, pp.79-83, 2010.
DOI : 10.1016/j.jss.2010.04.004

J. Wang, Y. Cai, and H. Ji, Serum IL-33 Levels Are Associated with Liver Damage in Patients with Chronic Hepatitis B, Journal of Interferon & Cytokine Research, vol.32, issue.6, pp.248-253, 2012.
DOI : 10.1089/jir.2011.0109

J. Wang, P. Zhao, and H. Guo, Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C, Mediators of Inflammation, vol.2012, 2012.

Y. Liang, Z. Jie, and L. Hou, IL-33 promotes innate IFN-?? production and modulates dendritic cell response in LCMV-induced hepatitis in mice, European Journal of Immunology, vol.464, issue.11, pp.3052-3063, 2015.
DOI : 10.1038/nature08900

Y. Liang, Z. Jie, and L. Hou, IL-33 Induces Nuocytes and Modulates Liver Injury in Viral Hepatitis, The Journal of Immunology, vol.190, issue.11, pp.5666-5675, 2013.
DOI : 10.4049/jimmunol.1300117

URL : http://www.jimmunol.org/content/jimmunol/190/11/5666.full.pdf

A. Jacques, C. Bleau, J. P. Martin, and L. Lamontagne, Intrahepatic endothelial and Kupffer cells involved in immunosuppressive cytokines and natural killer (NK)/NK???T cell disorders in viral acute hepatitis, Clinical & Experimental Immunology, vol.19, issue.2, pp.298-310, 2008.
DOI : 10.4049/jimmunol.170.10.5260

M. I. Arshad, S. Patrat-delon, and C. Piquet-pellorce, Pathogenic Mouse Hepatitis Virus or Poly(I:C) Induce IL-33 in Hepatocytes in Murine Models of Hepatitis, PLoS ONE, vol.293, issue.9, 2013.
DOI : 10.1371/journal.pone.0074278.s001

URL : https://hal.archives-ouvertes.fr/hal-00874120

M. Pichery, E. Mirey, and P. Mercier, Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33-LacZ Gene Trap Reporter Strain, The Journal of Immunology, vol.188, issue.7, pp.3488-3495, 2012.
DOI : 10.4049/jimmunol.1101977

C. Bleau, M. Burnette, A. Filliol, C. Piquet-pellorce, M. Samson et al., Toll-like receptor (tlr)-2 exacerbates murine acute viral hepatitis, Immunology, vol.49, issue.2, pp.204-224, 2016.
DOI : 10.1111/imm.12627

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011685

L. Houseman, M. Edwards, I. R. Phillips, and E. A. Shephard, Isolation and Culture of Mouse Hepatocytes: Gender-Specific Gene Expression Responses to Chemical Treatments, Methods in Molecular Biology, vol.1250, pp.3-12, 2015.
DOI : 10.1007/978-1-4939-2074-7_1

M. I. Arshad, C. Piquet-pellorce, and A. L. Helgoualc-'h, TRAIL but not FasL and TNF??, regulates IL-33 expression in murine hepatocytes during acute hepatitis, Hepatology, vol.31, issue.Suppl 1, pp.2353-2362, 2012.
DOI : 10.1016/j.immuni.2009.06.011

URL : http://onlinelibrary.wiley.com/doi/10.1002/hep.25893/pdf

F. Chalmel and M. Primig, The Annotation, Mapping, Expression and Network (AMEN) suite of tools for molecular systems biology, BMC Bioinformatics, vol.9, issue.1, p.86, 2008.
DOI : 10.1186/1471-2105-9-86

URL : https://hal.archives-ouvertes.fr/inserm-00521445

M. I. Arshad, C. Piquet-pellorce, and M. Samson, IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology, Liver International, vol.50, issue.Suppl. 1, pp.1200-1210, 2012.
DOI : 10.1002/hep.23021

URL : https://hal.archives-ouvertes.fr/hal-00874209

A. Jacques, C. Bleau, C. Turbide, N. Beauchemin, and L. Lamontagne, Macrophage interleukin-6 and tumour necrosis factor-?? are induced by coronavirus fixation to Toll-like receptor 2/heparan sulphate receptors but not carcinoembryonic cell adhesion antigen 1a, Immunology, vol.81, issue.1pt2, pp.181-192, 2009.
DOI : 10.4049/jimmunol.168.10.5139

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753892

C. Bleau, A. Filliol, M. Samson, and L. Lamontagne, ABSTRACT, Journal of Virology, vol.90, issue.20, pp.9096-9113, 2016.
DOI : 10.1128/JVI.01069-16

L. Mazaleuskaya, R. Veltrop, N. Ikpeze, J. Martin-garcia, and S. Navas-martin, Protective Role of Toll-like Receptor 3-Induced Type I Interferon in Murine Coronavirus Infection of Macrophages, Viruses, vol.81, issue.5, pp.901-923, 2012.
DOI : 10.1128/JVI.79.12.7629-7640.2005

P. Jolicoeur and L. Lamontagne, Impaired T and B cell subpopulations involved in a chronic disease induced by mouse hepatitis virus type 3, The Journal of Immunology, vol.153, issue.3, pp.1318-1317, 1994.

E. Bourgeois, L. P. Van, and M. Samson, The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-?? production, European Journal of Immunology, vol.40, issue.4, pp.1046-1055, 2009.
DOI : 10.4049/jimmunol.178.5.2706

URL : https://hal.archives-ouvertes.fr/hal-00356489

W. A. Verri-jr, F. O. Souto, and S. M. Vieira, IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy, Annals of the Rheumatic Diseases, vol.69, issue.9, pp.1697-1703, 2010.
DOI : 10.1136/ard.2009.122655

H. T. Le, V. G. Tran, W. Kim, J. Kim, H. R. Cho et al., IL-33 Priming Regulates Multiple Steps of the Neutrophil-Mediated Anti-Candida albicans Response by Modulating TLR and Dectin-1 Signals, The Journal of Immunology, vol.189, issue.1, pp.287-295, 2012.
DOI : 10.4049/jimmunol.1103564

C. Summers, S. M. Rankin, A. M. Condliffe, N. Singh, A. M. Peters et al., Neutrophil kinetics in health and disease, Trends in Immunology, vol.31, issue.8, pp.318-324, 2010.
DOI : 10.1016/j.it.2010.05.006

URL : https://doi.org/10.1016/j.it.2010.05.006

H. L. Van-sweringen, N. Sakai, and R. C. Quillin, Roles of hepatocyte and myeloid CXC chemokine receptor-2 in liver recovery and regeneration after ischemia/reperfusion in mice, Hepatology, vol.110, issue.1, pp.331-338, 2013.
DOI : 10.1182/blood-2007-02-073841

S. Kuboki, T. Shin, and N. Huber, Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice, Hepatology, vol.43, issue.4, pp.1213-1223, 2008.
DOI : 10.1016/j.molimm.2005.06.043

Q. Cao, R. Batey, G. Pang, A. Russell, and R. Clancy, IL-6, IFN-?? and TNF-?? production by liver-associated T cells and acute liver injury in rats administered concanavalin A, Immunology and Cell Biology, vol.159, issue.6, pp.542-549, 1998.
DOI : 10.1016/0168-8278(91)90836-Z

H. Ito, K. Ando, and T. Ishikawa, Role of TNF-?? Produced by Nonantigen-Specific Cells in a Fulminant Hepatitis Mouse Model, The Journal of Immunology, vol.182, issue.1, pp.391-397, 2009.
DOI : 10.4049/jimmunol.182.1.391

A. Antonelli, S. M. Ferrari, and C. Mancusi, Interferonalpha , -beta and -gamma induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor gamma agonists 15 Mediators of Inflammation Submit your manuscripts at https://www, Immunobiologyhindawi.com Stem Cells International, vol.218, issue.5, pp.690-695, 2013.